SCINAI IMMUNOTHERAPEUTICS LT (SCNI)
US09073Q3039 - ADR
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 4.70M | -6.50M | -5.80M | -12.38M | -1.30M | |||
| Depreciation Amortization | 1.23M | 514.00K | 562.00K | 747.70K | 708.50K | |||
| Change In Working Capital | -658.00K | -4.94M | 271.00K | -3.36M | -4.25M | |||
| Other non cash items | -11.76M | 1.54M | -2.30M | 7.41M | -16.26M | |||
| OPERATING CASH FLOW | -6.48M | -9.38M | -7.26M | -7.58M | -21.10M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -246.00K | -637.00K | -836.00K | -133.10K | -1.78M | |||
| Other Investing Activity | N/A | N/A | N/A | 21.40K | 57.30K | |||
| INVESTING CASH FLOW | -246.00K | -637.00K | -836.00K | -111.80K | -1.73M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | -377.70K | -360.70K | |||
| Stock Issued/Repurchased | 1.44M | 1.09M | 6.78M | 21.36M | 4.35M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 1.44M | 1.09M | 6.78M | 20.99M | 3.99M | |||
| Exchange Rate Effect | -25.00K | -272.00K | -1.98M | 519.20K | 498.00K | |||
| CHANGE IN CASH | -5.31M | -9.21M | -3.30M | 13.81M | -18.34M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -6.48M | -9.38M | -7.26M | -7.58M | -21.10M | |||
| Capital Expenditure | -246.00K | -637.00K | -836.00K | -133.10K | -1.78M | |||
| FREE CASH FLOW | -6.73M | -10.02M | -8.10M | -7.71M | -22.88M | |||
All data in USD